China Pharma Holdings
CPHI
8 hedge funds and large institutions have $159K invested in China Pharma Holdings in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
11% less funds holding
Funds holding: 9 → 8 (-1)
24% less capital invested
Capital invested by funds: $210K → $159K (-$51K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$18.4K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$7.28K |
| 3 |
JA
JOYN Advisors
Atlanta,
Georgia
|
+$117 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GA
Glenhill Advisors
New York
|
-$44K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$11K |
| 3 |
Renaissance Technologies
New York
|
-$4.23K |
| 4 |
VF
Virtu Financial
New York
|
-$3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2K |
CPHI Hedge Fund Activity: Q3 2018 in Review
8 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q3 2018, worth a combined $159K — down 24% from $210K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CPHI and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Susquehanna International Group, adding an estimated $18.4K. The largest seller was Glenhill Advisors, exiting entirely with an estimated $44K sold.
- 8 institutional investors held China Pharma Holdings (CPHI) as of Q3 2018, down from 9 in Q2 2018.
- Funds reported $159K of China Pharma Holdings stock for Q3 2018, down 24% quarter-over-quarter.
- 2 funds opened new China Pharma Holdings positions in Q3 2018 and 3 closed out, a net change of -1 holder.
- The largest China Pharma Holdings buyer in Q3 2018 was Susquehanna International Group, an estimated $18.4K added.
- The largest China Pharma Holdings seller in Q3 2018 was Glenhill Advisors, an estimated $44K sold.
Based on aggregated 13F filings for Q3 2018.